全文获取类型
收费全文 | 2554篇 |
免费 | 194篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 63篇 |
妇产科学 | 67篇 |
基础医学 | 267篇 |
口腔科学 | 176篇 |
临床医学 | 269篇 |
内科学 | 485篇 |
皮肤病学 | 83篇 |
神经病学 | 197篇 |
特种医学 | 45篇 |
外科学 | 319篇 |
综合类 | 69篇 |
一般理论 | 4篇 |
预防医学 | 235篇 |
眼科学 | 131篇 |
药学 | 175篇 |
中国医学 | 12篇 |
肿瘤学 | 147篇 |
出版年
2023年 | 30篇 |
2022年 | 57篇 |
2021年 | 117篇 |
2020年 | 77篇 |
2019年 | 116篇 |
2018年 | 85篇 |
2017年 | 70篇 |
2016年 | 80篇 |
2015年 | 88篇 |
2014年 | 102篇 |
2013年 | 145篇 |
2012年 | 183篇 |
2011年 | 173篇 |
2010年 | 101篇 |
2009年 | 81篇 |
2008年 | 126篇 |
2007年 | 144篇 |
2006年 | 111篇 |
2005年 | 113篇 |
2004年 | 99篇 |
2003年 | 96篇 |
2002年 | 52篇 |
2001年 | 34篇 |
2000年 | 44篇 |
1999年 | 35篇 |
1998年 | 15篇 |
1997年 | 18篇 |
1995年 | 8篇 |
1992年 | 22篇 |
1991年 | 28篇 |
1990年 | 22篇 |
1989年 | 35篇 |
1988年 | 21篇 |
1987年 | 17篇 |
1986年 | 14篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1981年 | 8篇 |
1979年 | 13篇 |
1977年 | 6篇 |
1975年 | 7篇 |
1974年 | 10篇 |
1973年 | 7篇 |
1972年 | 9篇 |
1971年 | 12篇 |
1969年 | 16篇 |
1968年 | 8篇 |
1967年 | 7篇 |
1966年 | 7篇 |
排序方式: 共有2757条查询结果,搜索用时 15 毫秒
31.
32.
33.
J.W. Lindsey U. Khan W. Ansari T. Powell Y.H. Wang M.S. Guirguis 《Journal of neuroimmunology》2013,254(1-2):146-153
Infection with Epstein–Barr virus (EBV) is associated with multiple sclerosis (MS), and patients with MS have an increased antibody response to some EBV antigens. The major antigens of EBV are only partly defined. Our hypothesis is that the antibody response to EBV is altered in MS. With ELISA, we found that antibodies to EB virions were increased in both serum and CSF of MS patients. Western blots demonstrated that there are multiple different antigens recognized. The antibody response was generally higher in MS to all EBV antigens, with particularly significant increases for certain antigens. We conclude that the antibody response to EBV in MS is generally increased with altered specificity. 相似文献
34.
35.
36.
37.
38.
39.
Sarah Heili Frades María del Pilar Carballosa de Miguel Alba Naya Prieto Marina Galdeano Lozano Xavier Mate García Ignacio Mahillo Fernández Itziar Fernández Ormaechea Laura Álvarez Suárez Farah Ezzine de Blas María José Checa Venegas Nicolás González Mangado Germán Peces Barba 《Archivos de bronconeumologia》2019,55(12):634-641
IntroductionHistorically, it has been assumed that Intermediate Respiratory Care Units (IRCU) were efficient, because they saved costs by reducing the number of admissions to intensive care units (ICU), and effective, because they specialized in respiratory diseases.MethodsThe number of IRCU admissions and mortality rate, historically and in 2016, were evaluated. For 2016, the grouped Related Diagnostic Groups (DRGs) were also described, and the savings achieved under all budgetary headings by avoiding UCI stays were calculated. A multivariate analysis was performed to associate costs with mean weights and complexity, and multiple logistic regression was performed on all patients admitted from 2004 to 2017 to describe the variables associated with mortality in our unit.ResultsAn IRCU generates savings of €500,000/year by reducing length of ICU stay. Analysis of the 2016 cohort shows that costs correlate with mean weight and mortality, and consequently complexity. The multivariate logistic regression analysis of the 2004–2017 cohort found respiratory frequency, leukopenia, anemia, hyperkalemia, and acidosis to be the variables best associated with mortality. The area under the curve for the logistic model was 0.75.ConclusionThe IRCU analyzed in our study was efficient in terms of ‘avoided costs’ and savings associated with complexity. Our results suggest that IRCUs have a lower mortality rate than other similar units, and are therefore a safe environment for patients. 相似文献
40.